Astigmatism and maternal myopia as important factors affecting success rate of DIMS lens treatment

Objective To assess the efficacy of myopia control spectacle lenses (defocus incorporated multiple segments/DIMS) in slowing myopia progression among a diverse Central European paediatric population and investigate the contribution of baseline parameters on treatment outcomes.Methods and analysis Th...

Full description

Saved in:
Bibliographic Details
Main Authors: Christof Meigen, Adrienne Csutak, Patricia Domsa, Éva M Bankó, Judit Körtvélyes, Rita Széchey, Krisztina Lantos, Zoltán Zsolt Nagy
Format: Article
Language:English
Published: BMJ Publishing Group 2024-05-01
Series:BMJ Open Ophthalmology
Online Access:https://bmjophth.bmj.com/content/9/1/e001499.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832086563620651008
author Christof Meigen
Adrienne Csutak
Patricia Domsa
Éva M Bankó
Judit Körtvélyes
Rita Széchey
Krisztina Lantos
Zoltán Zsolt Nagy
author_facet Christof Meigen
Adrienne Csutak
Patricia Domsa
Éva M Bankó
Judit Körtvélyes
Rita Széchey
Krisztina Lantos
Zoltán Zsolt Nagy
author_sort Christof Meigen
collection DOAJ
description Objective To assess the efficacy of myopia control spectacle lenses (defocus incorporated multiple segments/DIMS) in slowing myopia progression among a diverse Central European paediatric population and investigate the contribution of baseline parameters on treatment outcomes.Methods and analysis This retrospective observational study included 62 individuals aged 4–17 years (mean±SD: 10.21±2.70) with progressing myopia but without ocular pathology with a range of −0.88 to −8.25 D spherical equivalent refraction (SER) (−3.73±1.56), coupled with astigmatism up to −3.25 D cylindrical. All participants were prescribed DIMS (Hoya MiyoSmart) spectacles. Key outcome variables were cycloplegic SER, measured for all participants and axial length (AL), assessed in a subset of patients, recorded at baseline, 6 months and 12 months. Quality of life assessments were conducted at baseline, at 2 weeks, and 3, 6, 9 and 12 months. Additionally, parental myopic dioptre was recorded when applicable.Results At the 12-month mark, myopia progression in patients (mean±SE: −0.40±0.05) mirrored findings from prior European DIMS studies, but with 50% of patients showing no progression. A multivariate analysis of covariance model revealed that baseline astigmatism and younger age adversely affected therapy outcomes in both SER and AL, while severe maternal myopia led to greater SER progression. In contrast, only young age but not astigmatism was associated with AL increase in a comparable group of children with myopia, part of the LIFE Child Study, wearing single-vision spectacles. Patients reported consistent satisfaction with treatment, with minimal side effects, which diminished over the year.Conclusion In the European population, astigmatism, young age and severe maternal myopia are risk factors for suboptimal outcomes following DIMS therapy. Further research is necessary to elucidate the impact of astigmatism on myopic defocus therapy.
format Article
id doaj-art-30f3b1218f084a7bb0926b6aba83864f
institution Kabale University
issn 2397-3269
language English
publishDate 2024-05-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open Ophthalmology
spelling doaj-art-30f3b1218f084a7bb0926b6aba83864f2025-02-06T11:25:10ZengBMJ Publishing GroupBMJ Open Ophthalmology2397-32692024-05-019110.1136/bmjophth-2023-001499Astigmatism and maternal myopia as important factors affecting success rate of DIMS lens treatmentChristof Meigen0Adrienne Csutak1Patricia Domsa2Éva M Bankó3Judit Körtvélyes4Rita Széchey5Krisztina Lantos6Zoltán Zsolt Nagy7LIFE Leipzig Research Center for Civilization Diseases, Leipzig University, Leipzig, GermanyDepartment of Ophthalmology, University of Pécs Medical School, Pecs, HungaryNon Plus Ultra Vision Centre, Budapest, HungaryHUN-REN Research Centre for Natural Sciences, Budapest, HungaryNon Plus Ultra Vision Centre, Budapest, HungaryNon Plus Ultra Vision Centre, Budapest, HungaryDepartment of Ophthalmology, University of Pécs Medical School, Pecs, HungaryDepartment of Ophthalmology, Semmelweis University of Medicine, Budapest, HungaryObjective To assess the efficacy of myopia control spectacle lenses (defocus incorporated multiple segments/DIMS) in slowing myopia progression among a diverse Central European paediatric population and investigate the contribution of baseline parameters on treatment outcomes.Methods and analysis This retrospective observational study included 62 individuals aged 4–17 years (mean±SD: 10.21±2.70) with progressing myopia but without ocular pathology with a range of −0.88 to −8.25 D spherical equivalent refraction (SER) (−3.73±1.56), coupled with astigmatism up to −3.25 D cylindrical. All participants were prescribed DIMS (Hoya MiyoSmart) spectacles. Key outcome variables were cycloplegic SER, measured for all participants and axial length (AL), assessed in a subset of patients, recorded at baseline, 6 months and 12 months. Quality of life assessments were conducted at baseline, at 2 weeks, and 3, 6, 9 and 12 months. Additionally, parental myopic dioptre was recorded when applicable.Results At the 12-month mark, myopia progression in patients (mean±SE: −0.40±0.05) mirrored findings from prior European DIMS studies, but with 50% of patients showing no progression. A multivariate analysis of covariance model revealed that baseline astigmatism and younger age adversely affected therapy outcomes in both SER and AL, while severe maternal myopia led to greater SER progression. In contrast, only young age but not astigmatism was associated with AL increase in a comparable group of children with myopia, part of the LIFE Child Study, wearing single-vision spectacles. Patients reported consistent satisfaction with treatment, with minimal side effects, which diminished over the year.Conclusion In the European population, astigmatism, young age and severe maternal myopia are risk factors for suboptimal outcomes following DIMS therapy. Further research is necessary to elucidate the impact of astigmatism on myopic defocus therapy.https://bmjophth.bmj.com/content/9/1/e001499.full
spellingShingle Christof Meigen
Adrienne Csutak
Patricia Domsa
Éva M Bankó
Judit Körtvélyes
Rita Széchey
Krisztina Lantos
Zoltán Zsolt Nagy
Astigmatism and maternal myopia as important factors affecting success rate of DIMS lens treatment
BMJ Open Ophthalmology
title Astigmatism and maternal myopia as important factors affecting success rate of DIMS lens treatment
title_full Astigmatism and maternal myopia as important factors affecting success rate of DIMS lens treatment
title_fullStr Astigmatism and maternal myopia as important factors affecting success rate of DIMS lens treatment
title_full_unstemmed Astigmatism and maternal myopia as important factors affecting success rate of DIMS lens treatment
title_short Astigmatism and maternal myopia as important factors affecting success rate of DIMS lens treatment
title_sort astigmatism and maternal myopia as important factors affecting success rate of dims lens treatment
url https://bmjophth.bmj.com/content/9/1/e001499.full
work_keys_str_mv AT christofmeigen astigmatismandmaternalmyopiaasimportantfactorsaffectingsuccessrateofdimslenstreatment
AT adriennecsutak astigmatismandmaternalmyopiaasimportantfactorsaffectingsuccessrateofdimslenstreatment
AT patriciadomsa astigmatismandmaternalmyopiaasimportantfactorsaffectingsuccessrateofdimslenstreatment
AT evambanko astigmatismandmaternalmyopiaasimportantfactorsaffectingsuccessrateofdimslenstreatment
AT juditkortvelyes astigmatismandmaternalmyopiaasimportantfactorsaffectingsuccessrateofdimslenstreatment
AT ritaszechey astigmatismandmaternalmyopiaasimportantfactorsaffectingsuccessrateofdimslenstreatment
AT krisztinalantos astigmatismandmaternalmyopiaasimportantfactorsaffectingsuccessrateofdimslenstreatment
AT zoltanzsoltnagy astigmatismandmaternalmyopiaasimportantfactorsaffectingsuccessrateofdimslenstreatment